BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34578264)

  • 1. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
    Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
    Prezioso C; Zingaropoli MA; Iannetta M; Rodio DM; Altieri M; Conte A; Vullo V; Ciardi MR; Palamara AT; Pietropaolo V
    Mult Scler Relat Disord; 2020 Jun; 41():102008. PubMed ID: 32087593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
    Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
    Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.
    Ciardi MR; Zingaropoli MA; Iannetta M; Prezioso C; Perri V; Pasculli P; Lichtner M; d'Ettorre G; Altieri M; Conte A; Pietropaolo V; Mastroianni CM; Vullo V
    Virol J; 2020 Feb; 17(1):23. PubMed ID: 32046748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.
    Reid CE; Li H; Sur G; Carmillo P; Bushnell S; Tizard R; McAuliffe M; Tonkin C; Simon K; Goelz S; Cinque P; Gorelik L; Carulli JP
    J Infect Dis; 2011 Jul; 204(2):237-44. PubMed ID: 21673034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying drugs for multiple sclerosis and JC virus expression.
    Miller CS; Houff SA; Hopper J; Danaher RJ; Gurwell JA; Lin Y; Vega N; Berger JR
    J Neurovirol; 2012 Oct; 18(5):411-5. PubMed ID: 22585288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
    Domínguez-Mozo MI; García-Montojo M; Arias-Leal A; García-Martínez Á; Santiago JL; Casanova I; Galán V; Arroyo R; Fernández-Arquero M; Alvarez-Lafuente R
    Eur J Neurol; 2016 Jan; 23(1):182-9. PubMed ID: 26498276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
    Pietropaolo V; Bellizzi A; Anzivino E; Iannetta M; Zingaropoli MA; Rodio DM; Morreale M; Pontecorvo S; Francia A; Vullo V; Palamara AT; Ciardi MR
    J Neurovirol; 2015 Dec; 21(6):653-65. PubMed ID: 25930159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
    Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
    J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
    Shimbo E; Nukuzuma S; Tagawa YI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
    Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
    Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
    Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients.
    Agostini S; Mancuso R; Costa AS; Caputo D; Clerici M
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
    Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
    mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of JC virus and BK virus from a patient with progressive multifocal leukoencephalopathy with hyper IgM syndrome.
    Han GP; Miura K; Ide Y; Tsutsui Y
    J Med Virol; 2005 Jul; 76(3):398-405. PubMed ID: 15902714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment.
    Prezioso C; Ciotti M; Brazzini G; Piacentini F; Passerini S; Grimaldi A; Landi D; Nicoletti CG; Zingaropoli MA; Iannetta M; Altieri M; Conte A; Limongi D; Marfia GA; Ciardi MR; Mastroianni CM; Palamara AT; Moens U; Pietropaolo V
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
    Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
    J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
    Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A
    Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
    Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
    PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.